Intravenous immunoglobulin for the treatment of childhood encephalitis
作者： Mildred A Iro , Natalie G Martin , Michael Absoud , Andrew J Pollard
DOI: 10.1002/14651858.CD011367.PUB2
关键词: Medicine 、 Pathology 、 Antibody 、 Neurological dysfunction 、 Viral therapy 、 Inflammation 、 Glasgow Coma Scale 、 Immune system 、 Encephalitis 、 Parenchyma
摘要: Background Encephalitis is a syndrome of neurological dysfunction due to inflammation the brain parenchyma, caused by an infection or exaggerated host immune response, both. Attenuation through modulation response could improve patient outcomes. Biological agents such as immunoglobulin that have both anti‐inflammatory and immunomodulatory properties may therefore be useful adjunctive therapies for people with encephalitis.
cochrane.ir参考文章(78)
M D Kazatchkine, F Rossi, Y Sultan, Anti-idiotypes against autoantibodies and alloantibodies to VIII:C (anti-haemophilic factor) are present in therapeutic polyspecific normal immunoglobulins Clinical and Experimental Immunology. ,vol. 74, pp. 311- 316 ,(1988)
Kenneth L Tyler, Acute viral encephalitis. Handbook of Clinical Neurology. ,vol. 112, pp. 1171- 1181 ,(2013) , 10.1016/B978-0-444-52910-7.00038-6
Rajesh RamachandranNair, Mohemmad Rafeequ, Parameswaran Manoj, Ananthanarayanan Girija, Multimodal treatment of acute disseminated encephalomyelitis in children Journal of pediatric neurology. ,vol. 8, pp. 359- 365 ,(2015) , 10.3233/JPN-2010-0412
Noorbakhsh Samile, Tonekaboni Hassan, ACUTE DISSEMINATED ENCEPHALOMYELITIS IN CHILDREN. A DESCRIPTIVE STUDY IN TEHRAN, IRAN Saudi Medical Journal. ,vol. 28, pp. 396- 399 ,(2007)
I. Krause, R. Wu, Y. Sherer, M. Patanik, J. B. Peter, Y. Shoenfeld, In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations – a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases* Transfusion Medicine. ,vol. 12, pp. 133- 139 ,(2002) , 10.1046/J.1365-3148.2002.00360.X
Thanyalak Tha-In, Jagadeesh Bayry, Herold J. Metselaar, Srini V. Kaveri, Jaap Kwekkeboom, Modulation of the cellular immune system by intravenous immunoglobulin Trends in Immunology. ,vol. 29, pp. 608- 615 ,(2008) , 10.1016/J.IT.2008.08.004
Barbara A Rath, Max von Kleist, Maria E Castillo, Lenka Kolevic, Patricia Caballero, Giselle Soto-Castellares, Angela M Amedee, James E Robinson, David K Katzenstein, Russell B Van Dyke, Richard A Oberhelman, Antiviral Resistance and Correlates of Virologic Failure in the first Cohort of HIV-Infected Children Gaining Access to Structured Antiretroviral Therapy in Lima, Peru: A Cross-Sectional Analysis BMC Infectious Diseases. ,vol. 13, pp. 1- 12 ,(2013) , 10.1186/1471-2334-13-1
Marinos C Dalakas, The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile Pharmacology & Therapeutics. ,vol. 102, pp. 177- 193 ,(2004) , 10.1016/J.PHARMTHERA.2004.04.002
R. A. C. Hughes, M. C. Dalakas, D. R. Cornblath, N. Latov, M. E. Weksler, N. Relkin, Clinical applications of intravenous immunoglobulins in neurology Clinical and Experimental Immunology. ,vol. 158, pp. 34- 42 ,(2009) , 10.1111/J.1365-2249.2009.04025.X
J C van Swieten, P J Koudstaal, M C Visser, H J Schouten, J van Gijn, Interobserver agreement for the assessment of handicap in stroke patients. Stroke. ,vol. 19, pp. 604- 607 ,(1988) , 10.1161/01.STR.19.5.604